Case reference number (b)(4) is a spontaneous report sent on 14-apr-2021 by a (b)(6)-year-old female patient, reporting her own case.Additional information was received on 15-apr-2021 from patient herself.The patient's medical history included depression and sulfur allergies.The patient had previously received treatment with restylane and botox.Concomitant treatments included sertraline [sertraline] and bupropion [bupropion].It was unknown if patient had any other vaccines, illnesses or dental procedures in previous 6-12 months.On an unknown date in 2018, the patient received treatment with restylane defyne (unknown amount, lot number, injection technique and needle type) to nasolabial folds and above top lip.A month later, on an unknown date, the patient experienced hard lumps/bumpy(implant site mass), red(implant site erythema) and dry areas(injection site dryness) along the nasolabial folds and just under nose.The patient had tried herbs and lavender oil as corrective treatment.The hcp attempted to dissolve product with hyaluronidase [hyaluronidase] in 2019.On an unknown date in (b)(6) 2021, the patient received first dose of pfizer covid-19 vaccine.On (b)(6) 2021, the patient received second dose of pfizer covid-19 vaccine.On an unknown date in (b)(6) 2021, the hcp made another attempt to dissolve product with hyaluronidase, without improvement.The dermatologist was consulted who advised the use of steroids but it was refused by the patient.Outcome at the time of the report: hard lumps/bumpy was not recovered/not resolved.Red was not recovered/not resolved.Dry areas was not recovered/not resolved.
|